Výsledky vyhledávání - "Betzabel N, Cajiao Garcia"

Prevalence of KRAS p.(G12C) in stage IV NSCLC patients in the Netherlands; a nation-wide retrospective cohort study

Autor: Betzabel N. Cajiao Garcia, Léon C. van Kempen, Chantal C.H.J. Kuijpers, Ed Schuuring, Stefan M. Willems, Anthonie J. van der Wekken

Publikováno v: Lung Cancer, 167, 1-7. ELSEVIER IRELAND LTD

OBJECTIVES: The recent accelerated FDA approval of sotorasib, a highly selective KRAS G12C inhibitor, offers new opportunities for the treatment of KRAS p.(G12C)-mutated non-squamous non-small cell lung cancer (NSCLC). The objective of the current st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4326172768ae05bf38490aea7043eca
https://hdl.handle.net/11370/429b5ee5-98cf-4d71-8b3a-d53796a7252c

Zobrazit plný text záznamu

A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses

Autor: Ed Schuuring, Ronald A M Damhuis, Chantal C H J Kuijpers, Harry J.M. Groen, Anthonie J. van der Wekken, Léon C van Kempen, Bart Koopman, Stefan M. Willems, Betzabel N. Cajiao Garcia

Publikováno v: Cancers, 13(14):3641. MDPI AG
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3641, p 3641 (2021)

EGFR mutation analysis in non-small-cell lung cancer (NSCLC) patients is currently standard-of-care. We determined the uptake of EGFR testing, test results and survival of EGFR-mutant NSCLC patients in the Netherlands, with the overall objective to c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2028162816a5053b047a65bb5b46f0f
https://hdl.handle.net/11370/98148ad9-cbd3-4b68-9d43-a9d1983dbaf4

Zobrazit plný text záznamu

A Nationwide Study on the Impact of Routine Testing for

Autor: Bart, Koopman, Betzabel N, Cajiao Garcia, Chantal C H J, Kuijpers, Ronald A M, Damhuis, Anthonie J, van der Wekken, Harry J M, Groen, Ed, Schuuring, Stefan M, Willems, Léon C, van Kempen

Publikováno v: Cancers

Simple Summary The presence of an EGFR activating mutation in tumors of non-small-cell lung cancer patients enables effective targeted therapy towards EGFR. Studies that describe a nationwide uptake of EGFR testing, the impact of the switch from sing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5b20bed994227b44f1a368d43974f86d
https://pubmed.ncbi.nlm.nih.gov/34298851

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání